Related Experiment Video
Updated: Aug 13, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Cardiac surgical patients exposed to heparin-bonded circuits develop less postoperative cerebral dysfunction than
L B Mongero1, J R Beck, H E Manspeizer
1Department of Clinical Perfusion, The New York Presbyterian Medical Center, New York, USA. mongero@cpmail-am.cis.columbia.edu
Insights
Heparin-bonded circuits reduced cerebral dysfunction after cardiac surgery. This prospective trial found fewer abnormal neuropsychometric tests in patients using heparin-bonded cardiopulmonary bypass (CPB) circuits compared to non-heparin-bonded ones.
Area of Science:
- Cardiovascular Surgery
- Neuroscience
- Biomaterials Science
Background:
- Postoperative cerebral dysfunction is a concern following cardiac surgery.
- The systemic inflammatory response is a potential contributor to this dysfunction.
- Heparin-bonded circuits aim to mitigate inflammatory responses during cardiopulmonary bypass (CPB).
Purpose of the Study:
- To compare the incidence of cerebral dysfunction in patients undergoing CPB with heparin-bonded versus non-heparin-bonded circuits.
- To investigate the role of systemic inflammation in CPB-associated cerebral injury.
- To evaluate the neurocognitive outcomes in cardiac surgery patients.
Main Methods:
- Prospective randomized trial involving 39 elective coronary artery bypass (CABG) patients.
- Neuropsychometric tests (NPMTs) administered preoperatively, and at 5 days and 6 weeks postoperatively.
- Defined significant neurocognitive decline as a ≥25% decrease in NPMT performance from baseline.
Main Results:
- Patients with heparin-bonded circuits showed a lower percentage of abnormal NPMTs (>1 abnormal test) at 5 days postoperatively (58% vs. 70%).
- At 6 weeks postoperatively, fewer patients in the heparin-bonded group had abnormal NPMTs (36% vs. 63%).
- The Mann-Whitney rank test was used for analysis.
Conclusions:
- Heparin-bonded CPB circuits may reduce the incidence of cerebral injury in cardiac surgical patients.
- Attenuating systemic inflammation with heparin-bonded circuits appears beneficial for neurocognitive outcomes.
- Further research is warranted to confirm these findings and elucidate mechanisms.
Abstract:
A prospective randomized trial was used to study the incidence of cerebral dysfunction in patients undergoing cardiopulmonary bypass (CPB) with heparin-bonded vs non-heparin-bonded circuits. Although the etiology of postoperative cerebral dysfunction is controversial, activation of the systemic inflammatory response may play a role. After institutional approval and informed written consent, 39 elective coronary artery bypass (CABG) patients were studied. A battery of neuropsychometric tests (NPMTs) was performed preoperatively, and 5 days and 6 weeks postoperatively. Significant change in NPMT performance was defined as a 25% or greater decrease in postoperative performance, compared to baseline. The number of abnormal tests per patient was calculated. Analysis using the Mann-Whitney rank test was performed for the first follow-up. Patients randomized to heparin-bonded circuits had fewer abnormal NPMTs (>1 abnormal test) on postoperative day 5 (58 vs 70%, n=19 and 20) than patients randomized to non-heparin-bonded circuits. Patients exposed to heparin-bonded circuits had fewer abnormal tests (>1 abnormal test) at 6 weeks (36 vs 63%, n=14 and 16). Results suggested that the attenuation of systemic inflammation by heparin-bonded CPB circuits may lower the incidence of cerebral injury in cardiac surgical patients.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management

